Content about Pharmacology

January 2, 2014

With coverage under the Affordable Care Act now underway for millions of Americans, CVS Caremark has announced that it is ready to help patients who may experience coverage issues or have questions as they access care and prescription medications under new plans for the first time.

WOONSOCKET, R.I. — With coverage under the Affordable Care Act now underway for millions of Americans, CVS Caremark has announced that it is ready to help patients who may experience coverage issues or have questions as they access care and prescription medications under new plans for the first time.

January 2, 2014

The Kroger Co. has joined the list of retailers offering supplies of prescription drugs at no upfront cost to customers who have enrolled in the health insurance marketplaces, but have yet to receive an identification number.

CINCINNATI — The Kroger Co. has joined the list of retailers offering supplies of prescription drugs at no upfront cost to customers who have enrolled in the health insurance marketplaces, but have yet to receive an identification number.

The company announced Thursday that it would offer up to a 30-day supply of certain prescription drugs to customers who provide confirmation of their enrollment at one of the retailer's pharmacies.

January 2, 2014

A new mobile app-driven social network devoted to medical marijuana has attracted $150,000 in seed money from an investment group.

DENVER — A new mobile app-driven social network devoted to medical marijuana has attracted $150,000 in seed money from an investment group.

MassRoots announced Thursday that it had closed the seed investment from members of the ArcView Group. The social network, launched in July 2013, has more than 25,000 active users. MassRoots allows users to maintain their privacy and anonymity by not requiring their name, email or phone number to join.

January 2, 2014

The number of new drugs approved by the Food and Drug Administration fell by more than 30% in 2013 compared with 2012, according to agency records.

NEW YORK — The number of new drugs approved by the Food and Drug Administration fell by more than 30% in 2013 compared with 2012, according to agency records.

January 2, 2014

Patients who have enrolled in the new healthcare insurance marketplaces but haven't received an identification number from their insurers can receive up to a 30-day supply of prescription drugs at no upfront cost at Walgreens, the retail pharmacy chain said.

DEERFIELD, Ill. — Patients who have enrolled in the new healthcare insurance marketplaces but haven't received an identification number from their insurers can receive up to a 30-day supply of prescription drugs at no upfront cost at Walgreens, the retail pharmacy chain said.

January 2, 2014

Walmart is offering prescriptions at no upfront cost to patients who enroll in the public health insurance marketplace, the mass-merchandise retailer said.

BENTONVILLE, Ark. — Walmart is offering prescriptions at no upfront cost to patients who enroll in the public health insurance marketplace, the mass-merchandise retailer said.

December 30, 2013

The Food and Drug Administration has declined to approve a drug made by Genzyme Corp. for certain forms of multiple sclerosis, the company said Monday.

CAMBRIDGE, Mass. — The Food and Drug Administration has declined to approve a drug made by Genzyme Corp. for certain forms of multiple sclerosis, the company said Monday.

December 30, 2013

Drug maker Merck is starting a new business designed to provide weight-management intervention services to employers, patients and healthcare professionals, the company said.

WHITEHOUSE STATION, N.J. — Drug maker Merck is starting a new business designed to provide weight-management intervention services to employers, patients and healthcare professionals, the company said.

December 30, 2013

The owners of the compounding pharmacy linked to a nationwide meningitis outbreak that has killed dozens and sickened hundreds have agreed to set up a fund of more than $100 million to compensate victims and creditors.

BOSTON — The owners of the compounding pharmacy linked to a nationwide meningitis outbreak that has killed dozens and sickened hundreds have agreed to set up a fund of more than $100 million to compensate victims and creditors.

Legal firm Brown Rudnick announced that the owners of the New England Compounding Center had reached a settlement with bankruptcy trustee Paul Moore, its creditors and the victims to set up the fund, money from which will be distributed to creditors as well as victims who received injections of tainted steroids from NECC.

December 27, 2013

The Food and Drug Administration has approved an HIV pill made by Gilead Sciences for patients who are switching from other therapy regimens, the company said.

FOSTER CITY, Calif. — The Food and Drug Administration has approved an HIV pill made by Gilead Sciences for patients who are switching from other therapy regimens, the company said.

Gilead said the FDA approved its single-pill regimen, Complera (emtricitabine; rilpivirine; tenofovir disoproxil fumarate) for use in adult patients who have suppressed their infections on stable antiretroviral regimens and are replacing their current regimens. The FDA originally approved the drug in 2011.

December 26, 2013

The Food and Drug Administration declined to approve an experimental contraceptive patch developed by Actavis, the drug maker said Tuesday.

DUBLIN — The Food and Drug Administration declined to approve an experimental contraceptive patch developed by Actavis, the drug maker said Tuesday.

Actavis said the FDA sent it a complete response letter for its progestin-only transdermal contraceptive patch. A complete response letter means that the agency has finished reviewing a drug-approval application, but questions remain that preclude final approval.

December 26, 2013

Actavis said it was likely the first company to file with the Food and Drug Administration for approval of a generic version of a contraceptive device made by Merck, the generic drug maker said Tuesday.

DUBLIN — Actavis said it was likely the first company to file with the Food and Drug Administration for approval of a generic version of a contraceptive device made by Merck, the generic drug maker said Tuesday.

Actavis said Warner Chilcott, now one of its subsidiaries, had filed with the FDA for approval of the ethinyl estradiol and etonogestrel vaginal ring in the 0.015-mg-per-day and 0.12-mg-per-day strengths. The device is a generic version of Merck's NuvaRing.

December 26, 2013

Heading into 2014, there are a number of growth drivers across the digestives space.

Heading into 2014, there are a number of growth drivers across the digestives space. There’s the possible switch of Nexium into over-the-counter aisles, brands like Imodium are experiencing a resurgence with their return to the shelves, and Chattem is bringing the venerable Rolaids brand back into the digestives fold.

December 26, 2013

Sales of OTC female contraceptives ought to be significant in the coming year.

Sales of OTC female contraceptives ought to be significant in the coming year. Already, the category is up 2.3% to $232.7 million, and that number is expected to go up now that the Food and Drug Administration has approved Teva Women’s Health’s Plan B One-Step (levonorgestrel) without a prescription.

December 26, 2013

Earlier this year, the IMS Institute for Healthcare Informatics, the research wing of the healthcare industry analysis firm IMS Health, dropped a bombshell when it showed that U.S. spending on drugs fell in 2012, the first time that had happened in 55 years.

Earlier this year, the IMS Institute for Healthcare Informatics, the research wing of the healthcare industry analysis firm IMS Health, dropped a bombshell when it showed that U.S. spending on drugs fell in 2012, the first time that had happened in 55 years. But according to IMS’ latest figures, it was not the start of a trend.

December 23, 2013

A federal court decision paves the way for Amneal Pharmaceuticals and its South Korean partnering company to market a drug for treating gastroesophageal reflux disease, the companies said Monday.

BRIDGEWATER, N.J. — A federal court decision paves the way for Amneal Pharmaceuticals and its South Korean partnering company to market a drug for treating gastroesophageal reflux disease, the companies said Monday.

December 23, 2013

The Food and Drug Administration has approved revisions to the labeling of a leukemia drug made by Ariad Pharmaceuticals that allow the company to resume selling it, the company said.

CAMBRIDGE, Mass. — The Food and Drug Administration has approved revisions to the labeling of a leukemia drug made by Ariad Pharmaceuticals that allow the company to resume selling it, the company said.

December 23, 2013

The Food and Drug Administration has approved a new treatment made by Danish drug maker Novo Nordiskfor a rare, genetic bleeding disorder, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new treatment made by Danish drug maker Novo Nordiskfor a rare, genetic bleeding disorder, the agency said Monday.

December 20, 2013

Walgreens posted a first-quarter sales increase of 5.9% to a record $18.3 billion. Front-end comparable store sales for the quarter increased 2.4% in the first quarter, customer traffic in comparable stores increased 0.2% and basket size increased 2.2%, while total sales in comparable stores increased 5.4%. Prescription sales, which accounted for 64.7% of sales in the quarter ended Nov. 30, increased 7.3%, while prescription sales in comparable stores increased 7.2%.

Front-end comps are up. Prescription comps are up. Business is good. And that's not the story. Rather, that's the kind of results you can expect from the story. The story is Walgreens is priming a three-pistoned growth engine that will quite likely drive what pharmacy will look like in the future — an efficient global supply chain beast that feeds a front-end that commands traffic in its own right, and a back-end that demands healthcare payers pay attention to how Walgreens can help improve adherence and patient-care metrics. So, how can suppliers better align with Walgreens?

Walgreens posted a first-quarter sales increase of 5.9% to a record $18.3 billion. Front-end comparable store sales for the quarter increased 2.4% in the first quarter, customer traffic in comparable stores increased 0.2% and basket size increased 2.2%, while total sales in comparable stores increased 5.4%. Prescription sales, which accounted for 64.7% of sales in the quarter ended Nov. 30, increased 7.3%, while prescription sales in comparable stores increased 7.2%.

December 19, 2013

Bristol-Myers Squibb is selling its diabetes business to AstraZeneca for up to $4.3 billion as part of an effort to focus more on specialty drugs, the company said Thursday.

NEW YORK — Bristol-Myers Squibb is selling its diabetes business to AstraZeneca for up to $4.3 billion as part of an effort to focus more on specialty drugs, the company said Thursday.

BMS said AstraZeneca would pay $2.7 billion upfront, as well as up to $1.4 billion in milestone payments and up to $225 million on the condition of certain assets being sold. The companies have had a diabetes drug-development partnership since 2007.

December 19, 2013

While more than half of Americans don't agree with legalizing the sale and possession of small amounts of marijuana for recreational use, most also say that if legal, it should be sold at pharmacies, according to a new survey.

NEW YORK — While more than half of Americans don't agree with legalizing the sale and possession of small amounts of marijuana for recreational use, most also say that if legal, it should be sold at pharmacies, according to a new survey.

December 19, 2013

The National Community Pharmacists Association on Thursday announced the need for legislation in Pennsylvania to protect independent pharmacy operators there.

ALEXANDRIA, Va. — The National Community Pharmacists Association on Thursday announced the need for legislation in Pennsylvania to protect independent pharmacy operators there. 

December 19, 2013

Abuse of the cough ingredient dextromethorphan among high school seniors is down, according to this year’s Monitoring the Future survey, which measures drug use and attitudes among the nation’s eighth-, 10th- and 12th-graders.

ROCKVILLE, Md. — Abuse of the cough ingredient dextromethorphan among high school seniors is down, according to this year’s Monitoring the Future survey, which measures drug use and attitudes among the nation’s eighth-, 10th- and 12th-graders. Approximately 5% of seniors reported abuse of dextromethorphan, down from 6.9% in 2006, the first year it was measured by the survey.

December 18, 2013

Actelion has launched a topical gel used to treat a kind of skin cancer, the company said.

SOUTH SAN FRANCISCO, Calif. – Actelion has launched a topical gel used to treat a kind of skin cancer, the company said.

Actelion announced the launch of Valchlor (mechlorethamine), which the Food and Drug Administration approved in August for treating stage 1A and 1B mycosis fungoides-type cutaneous T-cell lymphoma in patient who have received skin-directed therapy before. Actelion acquired rights to the drug when it merged with Ceptaris Therapeutics. Accredo Specialty Pharmacy distributes the drug in the United States.

December 18, 2013

The Food and Drug Administration and the European Medicines Agency will share data about studies meant to show whether generic drugs are equivalent to their branded counterparts, under a joint program announced Wednesday.

SILVER SPRING, Md. — The Food and Drug Administration and the European Medicines Agency will share data about studies meant to show whether generic drugs are equivalent to their branded counterparts, under a joint program announced Wednesday.